Class 4 Laser for Fungus Nails, Heel Pain, Achilles Pain, Sports Injuries and Verruca
  • Home
  • About Us
  • Servicesskip-track2
    • Services
    • Prices
  • Contact
  • Blog
  • Our Specialists
  • Book Online
Location
Clinic Locations
  • placeholder-for-map-1Studio 404  Green House Custard Factory  Gibb St Birmingham, B9 4AA – Digbeth
  • placeholder-for-map-1The Podiatry Clinic Limited 15 High Street Harborne Birmingham B17 9NT – Harborne
  • placeholder-for-map-1Footmedic Podiatry Surgery 29 Rookery Road Handsworth Birmingham,  B21 9QU – Handsworth
Contact Info
  • telephone-1Phone: 0121 285 1367 -Digbeth
  • telephone-1Phone: 0121 285 5656 -Harborne
  • telephone-1Phone: 0121 523 5885 -Handsworth
  • black-envelopeinfo@midlandlaserclinic.co.uk
Working Time
  • icon-3
    Mon-Fri 09:00 – 18:00
    Saturday 09:00 – 13:00

Get In Touch With Us

For general questions, please send us a message and we’ll get right back to you. You can also call us directly to speak with a member of our team.

    How We Can Help
    • Class 4 Laser and Shockwave Treatment
      • right-arrowMuscle and Ligament Injuries
      • right-arrowVerruca
      • right-arrowFungus Nails
      • right-arrowSpider Veins
      • right-arrowNerve Pain
      • right-arrowHeel Pain
      • right-arrowAchilles  Pain
      • right-arrowMetatarsalgia
      • right-arrowNeuroma
      • right-arrowOsteoarthritis
    Working Time
    • clockMon-Fri 09:00 – 18:00
      Saturday 09:00 – 16:00
    Contact Info
    • clockPhone: 1-800-267-0000
      1-800-267-0001

    Class 4 Laser and Extra-Corpeal Shockwave Treatment

    Contact
    Clinic Locations
    • placeholder-for-map-1Studio 404  Green House Custard Factory  Gibb St Birmingham, B9 4AA – Digbeth
    • placeholder-for-map-1The Podiatry Clinic Limited 15 High Street Harborne Birmingham B17 9NT – Harborne
    • placeholder-for-map-1Footmedic Podiatry Surgery 29 Rookery Road Handsworth Birmingham,  B21 9QU – Handsworth
    Contact Info
    • telephone-1Phone: 0121 285 1367 -Digbeth
    • telephone-1Phone: 0121 285 5656 -Harborne
    • telephone-1Phone: 0121 523 5885 -Handsworth
    • black-envelopeinfo@midlandlaserclinic.co.uk
    Working Time
    • icon-3
      Mon-Fri 09:00 – 18:00
      Saturday 09:00 – 13:00

    Get In Touch With Us

    For general questions, please send us a message and we’ll get right back to you. You can also call us directly to speak with a member of our team.

      Book Appointment
      Clinic Locations
      • placeholder-for-map-1Studio 404  Green House Custard Factory  Gibb St Birmingham, B9 4AA – Digbeth
      • placeholder-for-map-1The Podiatry Clinic Limited 15 High Street Harborne Birmingham B17 9NT – Harborne
      • placeholder-for-map-1Footmedic Podiatry Surgery 29 Rookery Road Handsworth Birmingham,  B21 9QU – Handsworth
      Contact Info
      • telephone-1Phone: 0121 285 1367 -Digbeth
      • telephone-1Phone: 0121 285 5656 -Harborne
      • telephone-1Phone: 0121 523 5885 -Handsworth
      • black-envelopeinfo@midlandlaserclinic.co.uk
      Working Time
      • icon-3
        Mon-Fri 09:00 – 18:00
        Saturday 09:00 – 13:00

      Get In Touch With Us

      For general questions, please send us a message and we’ll get right back to you. You can also call us directly to speak with a member of our team.

        Services
        • Class 4 Laser and Shockwave Treatment
          • right-arrowMuscle and Ligament Injuries
          • right-arrowVerruca
          • right-arrowFungus Nails
          • right-arrowSpider Veins
          • right-arrowNerve Pain
          • right-arrowHeel Pain
          • right-arrowAchilles  Pain
          • right-arrowMetatarsalgia
          • right-arrowNeuroma
          • right-arrowOsteoarthritis
        Working Time
        • clockMon-Fri 09:00 – 18:00
          Saturday 09:00 – 16:00
        Contact Info
        • clockPhone: 1-800-267-0000
          1-800-267-0001

        Class 4 Laser and Extra-Corpeal Shockwave Treatment

        top
        +
        HomeBlog Posts
        22Nov

        Class 4 Lasers and Podiatry!

        by admin

        Before implementing any new treatment modality to our practice, there are always two questions we ask:

        • Why do we want to offer this treatment?

        • What are the goals of this treatment?

        Fortunately, the answers are simple and consistent over time. Ideally, you always want treatments that result in improved outcomes for our patients at a affordable price.

        Additionally, when evaluating treatment modalities for one’s practice, clinicians should seek out modalities that are less invasive and have low levels of risk while still offering the potential for high reward. This is not only a best practice but generally our patients are already looking for options that meet these criteria.

        How many people do you know who love local steroid injections, taking systemic medications, spending hours in physical therapy, and, of course, having surgery? Not many! In our experience, class IV laser therapy not only provides an option that our patients will typically accept, it also meets the key criteria of positive outcomes.

        However, not all lasers are created equal. In order to achieve all of the goals you have set with incorporating new treatment modalities into our practice, opting for a laser that is multi-functional (provides treatment for pain/inflammation, therapy, warts and fungus) is critical.

        Assessing The Potential Benefits Of Class IV Laser Therapy

        A laser is considered a class IV laser when it exceeds 500 mw.1 Other considerations the podiatrists should understand when accessing class IV lasers include power density and wavelength.

        In regard to power density, which is the amount of energy in a specific area over time, dosage refers to the amount of energy per unit of tissue surface. Energy is measured in joules, the area in square centimeters, and thus the dosage is in joules per centimeter (J/cm2).

        The podiatrist must ensure the proper energy dosage into the target area (i.e. the insertion of the plantar fascia, a painful joint or a non-healing wound). One must sustain the energy in the target area in order to create a photochemical cascade, which is also known as photobiomodulation. Photobiomodulation stimulates the chromophores on the mitochrondrial membranes, which incite the production of adenosine triphosphate (ATP).2 Adenosine triphosphate production is important because it stores chemical energy and releases it to the biochemical processes occurring in the cell.

        Wavelength in lasers is very important, along with peak and sustained power, which determines whether the proper dosage arrives at the target area that needs photochemical stimulation.

        To effectively penetrate and treat target cells, therapy lasers should emit in the 800-1000 nm range. This range is referred to as therapeutic window for photobiomodulation. One should treat target tissue in which there is pathology within these wavelength parameters.3

        With Class IV lasers, podiatrists should have proper training on these devices as there are safety risks with their use. Some important risks to consider are vision injury due to unprotected direct exposure to the laser and skin burns due to improper application. 

        Can Class IV Laser Treatment Have An Impact For These Conditions?

        Therapeutic lasers (also known as pain lasers) stimulate cell function. Surgical lasers collimate high amounts of energy into a beam, resulting in tissue cutting or ablation, there are single lasers that can do both.2

        In our experience, we have also found class IV lasers beneficial in the treatment of inflammation, pain and arthritic joints, onychomycosis and mosaic warts. Clinicians may also employ these lasers to help facilitate wound care, fracture care and physical therapy applications.2 

        Plantar fasciitis and Achilles tendonitis. Laser therapy is an excellent alternative to local corticosteroid injections and/or non-steroidal anti-inflammatory drugs (NSAIDs) for plantar fasciitis and Achilles tendonitis. One must treat the inflammation along with any lack of range of motion such as ankle equinus. In my personal experience developing laser protocols for these conditions, I have found that lasers can increase the mobility of joints and their associated tendons and ligaments. Our observation is that the use of the laser along the entire Achilles tendon and ankle joint can increase range of motion at the ankle joint.

        The photochemical reactions that occur with laser therapy lead to reduction or elimination of pain, as well as the ability to heal inflammatory conditions like plantar fasciitis and Achilles tendonitis.2 

        Physical therapy or post-surgical rehabilitation. One may use laser therapy for acute conditions such as post-op or post-injury swelling, pain and lack of joint mobility. Class IV laser therapy may provide a more comfortable and economical alternative to physical therapy. Outcomes are often as positive as for physical therapy or better.3

        Post-surgical incisions and wounds. Scar tissue may form due to excessive post-surgical inflammation. Employing a laser with proper settings/protocols may help reduce inflammation and subsequently lead to less scar formation.4

        Neuroma. When neuromas occur secondary to inflammation in any intermetatarsal space, one may consider a class IV laser. Many times, there are other conditions such as capsulitis, bursitis and/or tendonitis associated with the neuroma. By learning how to treat these pathologies with a laser, in our experience, the podiatrists may address all of the associated compensatory problems versus solely focusing on one intermetatarsal space.

        Neuropathy. In our experience, many clinics use class IV Lasers for patients who present with neuropathy. Lasers may provide adjunctive benefit as part of a comprehensive approach for these patients. In a 2015 study, Cg and colleagues demonstrated that therapy lasers can be very beneficial in the treatment of diabetic peripheral neuropathy.5

        Onychomycosis. There are class IV lasers that are FDA-cleared for this indication and can provide adjunctive benefit. Understanding the role of power density and reactive oxygen species is important along with ensuring appropriate concomitant treatment. Having a class IV laser that has multiple FDA-cleared indications is a major benefit as opposed to purchasing multiple lasers for multiple indications.

        Ablative and non-ablative treatment of verrucae. Having a class IV laser with both surgical and non-surgical capabilities increases your treatment options. Adherence to FDA-cleared protocols is very important. The laser device should have the ability to not only cut out or ablate a wart, but also be able to treat mosaic warts without any use of a local anesthetic. Lasers do not only cut and coagulate. They can stimulate the immune system to treat plantar verrucae.6

        Final Notes

        Class IV lasers can be a huge game-changer for our patients. When assessing lasers or any medical device, we look for the following keys.

        • Effectiveness.

        • Affordability for patients.

        References

        1. Virginia Tech. Environmental Health and Safety. Laser Safety Classification. Available at: https://www.ehss.vt.edu/programs/LAS_classification.php . Accessed December 3, 2020.

        2. Tunér J, Hode L. The New Laser Therapy Handbook. Roseville, Calif.: Prima Books; 2016: 29, 74-75, 153, 160, 293

        3. Takenori A, Ikuhiro M, Shogo, U, et al. Immediate pain relief effect of low level laser therapy for sports injuries: Randomized, double-blind placebo clinical trial. J Sci Med Sport. 2016;19(12):980-983.

        4. Kawalec J, Logan J, Hetherington V, Penfield V. Evaluation of the effect of one-weekly treatments with the Ceralas D Diode Laser on wound healing. Independence, Oh.: Ohio College of Podiatric Medicine Research Foundation; 2002.

        5. Cg SK, Hande HM, Vidyasagar S, Rao K, Rajagopal KV. Efficacy of low level laser therapy on painful diabetic peripheral neuropathy. Laser Ther. 2015;24(3), 195-200.

        6. Kneebone WJ. Immune-modulating effects of therapeutic laser. Practical Pain Management. 2010:10(9). Available at: https://www.practicalpainmanagement.com/treatments/complementary/lasers/immune-modulating-effects-therapeutic-laser . Updated March 7, 2011. Accessed November 20, 2020.

        19Apr

        Evidence: Laser Vs Laser and Shockwave Pain Patient Satisfaction Evaluation of 100 Patients

        by admin

        https://www.high-intensity-laser.com/hil-versus-hil-and-rswt-pain-and-patient-satisfaction-evaluation-of-100-patients

        In this study we want to evaluate 100 patients with chronic tendon and bone pathologies treated with one or both therapies.

        Methods: 

        91 patients were treated with HIL and 9 with HIL and RSWT. We evaluate pain and patient satisfaction prospectively after 5 sessions HIL. The same parameters were assessed in patients with combined therapy after 5 sessions HIL and 3 sessions RSWT.

        Study results: 

        Pain relief average was 68.6% and patient satisfaction average 89.8% in patients treated only with HIL. Pain relief was 41% and patient satisfaction 85.7% in combined treatment.

        Discussion: 

        This is a preliminary clinical study to evaluate only subjective parameters, without excluding other therapies that patients were doing when they started these treatments. We did not separate pathologies one by one, so with these findings we can only have a general vision of the use of these therapies. We need another objective research (clinical and histhological), with control group, also animal research, to confirm these findings.

        Conclusion:

        We conclude that both therapies were helpful in pain relief and also patient satisfaction. Further studies will be necessary, separating by pathologies, including samples for histological study in tissues treated with one or both techniques, that must be analysed in the laboratory, to confirm these results.

        Source:

        18th International Congress of the International Society for Medical Shockwave Treatment, 2015

        24Mar

        Class 4 Laser Verruca Session 2

        by admin

        14Mar

        Class 4 Laser Treatment for Verruca

        by admin
        13Mar

        Evidence: Laser treatment is the preferred treatment for troublesome varicose veins

        by admin

        Initial results from this trial (CLASS) found that the three main treatments for varicose veins all improved symptoms and quality of life six months after treatment. On a balance of scores, laser treatment was more effective than foam treatment or surgery.

        Laser involved fewest complications six weeks after the procedure and may be the most cost effective option in the long term. Foam was the most cost effective option at six months and enabled the most rapid recovery but was less effective than laser or surgery.

        The NIHR funded CLASS trial results are in line with current NICE guidance to offer minimally invasive treatments in preference to surgery. A change in practice towards these treatments could be cost saving to the NHS.

        Why was this study needed?

        Varicose veins are swollen, enlarged veins with damaged valves and disrupted blood flow. They usually occur in the legs. As a result, the veins form unsightly bulges near the skin surface. The impact of varicose veins ranges from cosmetic effects, to troublesome symptoms such as itching, aching legs, cramps and lower leg fluid retention, to more severe complications such as bleeding and leg ulcers. Around a third of the UK population have visible varicose veins, and in 2009/10 nearly 36,000 procedures were carried out by the NHS to treat varicose veins. Surgery to remove damaged sections of varicose veins is the longest-established treatment, but is costly and involves one to three weeks recovery. This study compared the effectiveness and quality of life improvements of two less invasive operations, foam and laser therapy, with surgery.

        What did this study do?

        The CLASS trial was carried out at 11 UK hospitals and included 798 patients with troubling symptoms of varicose veins. They were randomly allocated to one of three treatments: foam (foam sclerotherapy), laser (endovascular laser ablation) or surgery. Surgery was a one-stage process, whereas laser and initial foam therapy could be followed by foam six weeks later if varicose veins remained. The main outcome was patient reported quality of life six months after the procedure.

        The CLASS study data were combined with existing data on long-term treatment effects to estimate clinical and cost-effectiveness at five years after the initial treatment. A limitation of the study was that it did not measure long term recurrence of varicose veins. Also, it did not study radiofrequency ablation, a minimally invasive treatment like laser treatment.

        What did it find?

        • All three treatments were effective at treating varicose veins and improved quality of life at six months after treatment (for example, in each group, quality of life improved by an average of around 9 points on a 0-100 disease-specific scale, the Aberdeen Varicose Vein Questionnaire).
        • Laser and surgery were more successful at treating varicose veins than foam at six months after treatment.
        • Based on costs to health services and patients by 6 months, estimates of long-term cost effectiveness showed that laser was the option most likely to be cost effective at usual NHS thresholds. In a five year model, laser was most likely to be value for money (79% probability), followed by foam (17% probability), then surgery (5% probability).
        • Foam had the most complications at six months, of which the most common were lumpiness, skin staining and tenderness. This treatment gave the smallest quality of life improvement and was least likely to close the vein.

        What does current guidance say on this issue?

        Where there is damage to leg vein valves and impaired blood flow, or troublesome symptoms such as aching legs, 2013 NICE guidance recommends treatment using minimally invasive procedures. The first choice is endothermal ablation (which includes laser), the second is foam. If neither is suitable, surgery is the final option. NICE will make a decision about whether to update this guidance in September 2015.

        What are the implications?

        Initial results from the CLASS trial broadly support current NICE guidance in terms of the best order to offer varicose vein treatments. Five year results from the trial will include recurrence rate of varicose veins for the three options. This could change estimates of long-term cost effectiveness. Also approaches to carrying out radiofrequency ablation are changing. These changes may have an impact on future guidance.

        The CLASS trial provides evidence that choosing less invasive procedures such as laser and foam therapy over surgery can offer cost savings in the longer term. However, foam led to slightly smaller quality of life improvements and more complications compared with laser or surgery.

        A NICE costing report and template was produced in 2013 to model the impact for local health communities that follow its recommendations. An estimated 27,084 interventional procedures were carried out in the UK to treat varicose veins in 2011. If the referral patterns changed as expected, the proportion of surgical procedures would reduce from 52% to 5%, with increases in endothermal ablation including laser from 35% to 70% and in foam treatments from 13% to 25%. This could create a net saving of £7,800 per year per 100,000 population.

        Citation

        Brittenden J, Cotton SC, Elders A, et al. Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technol Assess. 2015;19(27):1-342.

        This project was funded by the National Institute for Health Research HTA Programme (project number 06/45/02).

        Bibliography

        Brittenden J, Cotton SC, Elders A, et al. A randomized trial comparing treatments for varicose veins. NEJM. 2014;371:1218-27.

        Knott, L. Varicose veins. PatientPlus. Leeds: EMIS Group; 2013

        NICE. Endovenous laser treatment of the long saphenous vein. IPG52. London: National Institute for Health and Care Excellence; 2004.

        NICE. Ultrasound-guided foam sclerotherapy for varicose veins. IPG440. London: National Institute for Health and Care Excellence; 2013.

        NICE. Varicose veins in the legs. NICE Pathway. London: National Institute for Health and Care Excellence; 2015.

        NICE. Varicose veins in the legs: the diagnosis and management of varicose veins. CG168. London: National Institute for Health and Care Excellence; 2013.

        NICE CKS. Varicose veins. London: National Institute for Health and Care Excellence; 2014.

        Tassie E, Scotland G, Brittenden J, et al., on behalf of the CLASS Study team. Cost-effectiveness of ultrasound guided foam sclerotherapy (UGFS), endovenous laser ablation (EVLA), and surgery as treatments for primary varicose veins: results based on the CLASS trial. Br J Surg. 2014;101(12):1532-40.

        Veins. General Information – Varicose Veins. London: Circulation Foundation; [2015]

        Produced by the University of Southampton and Bazian on behalf of NIHR through the NIHR Dissemination Centre

        12Mar

        Evidence: High Power Laser for Treatment of Achilles Tendinosis – a Single Blind Randomized Placebo Controlled Clinical Study

        by admin

        https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909008/

        Abstract

        Introduction: Pain in the Achilles tendon during loading is a very common condition. Conservative treatments, such as low level laser therapy (LLLT) have been reported to give varying results. Recently, a new laser treatment technique, high power laser treatment (HPLT) (Swiss DynaLaser®), was introduced in Scandinavia, but has not, to our knowledge, been systematically tested before. The objective of this study was to evaluate the effects of HPLT compared to placebo HPLT in rated pain and assessed pain threshold in patients with chronic Achilles tendinosis.

        Methods: The study was a randomized, single blind, placebo controlled trial. Patients were randomized to receive 6 treatments of either HPLT or placebo HPLT during a period of 3-4 weeks with a follow up period of 8-12 weeks. Outcome measures were rated pain according to questions of the Foot and Ankle Outcome Score (FAOS, Swedish version LK1.0) and assessment of electro-cutaneous stimulated pain threshold and matched pain (PainMatcher).

        Results: The results of the study demonstrated significant changes of assessments within groups, that were more pronounced towards lower levels of rated pain in the HPLT group than in the placebo HPLT group. The between group difference were significant in four of nine questions regarding loading activities of the FAOS subscale. Assessed pain thresholds were found increased in the HPLT group, as compared to the placebo HPLT group. At individual level, the results varied.

        Conclusion: The results indicate that HPLT may provide a future option for treatment of Achilles tendinosis related pain, but further studies are warranted.

        7Mar

        Evidence: Treatment of mild, moderate, and severe onychomycosis (fungal nails) using 870- and 930-nm light exposure

        by admin

        https://pubmed.ncbi.nlm.nih.gov/20479446/

        Abstract
        Background: Dual-wavelength near-infrared diode laser used to treat onychomycosis (fungal nails). The device operates at physiologic temperatures that are thermally safe for human tissue. It uses only 870- and 930-nm near-infrared light, wavelengths that have unique photolethal effects on fungal pathogens. These wavelengths lack the teratogenic danger presented by ultraviolet light and the photoablation toxic plume associated with pulsed Nd:YAG lasers.

        Methods: In this randomized controlled study, treatments followed a predefined protocol and laser parameters and occurred on days 1, 14, 42, and 120. Toes were cultured and evaluated, and measurements were taken from standardized photographs obtained periodically during the 180 day follow-up period.

        Results: We treated mycologically confirmed onychomycosis in 26 eligible toes (ten mild, seven moderate, and nine severe). All of the patients were followed-up for 180 days. An independent expert panel, blinded regarding treatment versus control, found that at 180 days, 85% of the eligible treated toenails were improved by clear nail linear extent (P = .0015); 65% showed at least 3 mm and 26% showed at least 4 mm of clear nail growth. Of the 16 toes with moderate to severe involvement, ten (63%) improved, as shown by clear nail growth of at least 3 mm (P = .0112). Simultaneous negative culture and periodic acid-Schiff was noted in 30% at 180 days.

        Conclusions: These results indicate a role for this laser in the treatment of onychomycosis, regardless of degree of severity. Ease of delivery and the lack of a need to monitor blood chemistry are attractive attributes.

        • 1
        • 2
        • 3
        • right-arrow

        Date Posts

        June 2025
        M T W T F S S
         1
        2345678
        9101112131415
        16171819202122
        23242526272829
        30  
        « Apr    

        Tags

        class 4 laser remy laser

        Recent Posts

        Class 4 Lasers and Podiatry!

        Class 4 Lasers and Podiatry!

        November 22, 2020
        Class 4 Laser for Fungus Nails

        Class 4 Laser for Fungus Nails

        November 22, 2020
        Benefits of Class 4 Laser

        Benefits of Class 4 Laser

        February 22, 2021

        Archives

        • April 2021
        • March 2021
        • February 2021
        • November 2020
        • February 2020

        Blog Posts

        Class 4 Lasers and Podiatry!
        Class 4 Lasers and Podiatry!

        November 22, 2020

        Class 4 Laser for Fungus Nails
        Class 4 Laser for Fungus Nails

        November 22, 2020

        Benefits of Class 4 Laser
        Benefits of Class 4 Laser

        February 22, 2021

        Class 4 Laser and Diabetic Wound healing
        Class 4 Laser and Diabetic Wound healing

        February 23, 2021

        Extracorporeal shockwave therapy (ESWT) for Achilles tendinopathy and plantar fasciitis
        Extracorporeal shockwave therapy (ESWT) for Achilles tendinopathy and plantar fasciitis

        February 24, 2021

        Our Contacts

        • placeholder-for-map-1Studio 404 Green House Custard Factory Gibb St Birmingham, B9 4AA - Digbeth
        • placeholder-for-map-1The Podiatry Clinic Limited 15 High Street Harborne Birmingham B17 9NT – Harborne
        • placeholder-for-map-1Footmedic Podiatry Surgery 29 Rookery Road Handsworth Birmingham, B21 9QU – Handsworth
          placeholder-for-map-1Get directions on the mapright-arrow
        • telephone-10121 285 1367 - - Digbeth
        • telephone-10121 285 5656 -Harborne
        • telephone-10121 523 5885 -Handsworth
        • black-envelopeinfo@midlandlaserclinic.co.uk
        up-arrow-1